Balyasny Asset Management LLC Lucira Health, Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.83 $6,068 - $45,789	-55,168 Reduced 16.91%	271,030 $29,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.94 $469,725 - $1.29 Million	326,198 New	326,198 $607,000
Q4 2021 Feb 14, 2022	SELL	$4.94 - $8.94 $461,588 - $835,344	-93,439 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.81 $346,205 - $618,591	57,224 Added 158.01%	93,439 $710,000
Q2 2021 Aug 16, 2021	SELL	$4.56 - $11.45 $293,632 - $737,299	-64,393 Reduced 64.0%	36,215 $240,000
Q1 2021 May 17, 2021	BUY	$11.65 - $37.0 $1.17 Million - $3.72 Million	100,608 New	100,608 $1.22 Million

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.